Italia markets closed

ILMN May 2024 145.000 call

OPR - OPR Prezzo differito. Valuta in USD.
Aggiungi a watchlist
0,0400-0,0800 (-66,67%)
In data: 10:13AM EDT. Mercato aperto.
Schermo intero
Chiusura precedente0,1200
Aperto0,7400
Denaro0,0000
Lettera0,2000
Prezzo d'esercizio145,00
Scadenza2024-05-03
Min-Max giorno0,0400 - 0,7400
Contratto - Min-MaxN/D
Volume2
Open Interest107
  • GlobeNewswire

    Myriad Genetics and Illumina Achieve Milestones in Strategic Partnership to Support Biopharma Clinical Trials

    Myriad can conduct prospective clinical trials using Illumina’s TruSight Oncology Comprehensive Investigational Use Only testSALT LAKE CITY, Sept. 19, 2023 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (NASDAQ: MYGN), a leader in genetic testing and precision medicine, today announced two key milestones in its strategic partnership with Illumina Inc. (NASDAQ: ILMN), a global leader in DNA sequencing and array-based technologies, to advance and support clinical research for gene-based, targeted thera